Guangyu Sun Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

1/2023	The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study.
1/2022	Allogeneic double-negative T cell therapy for relapsed acute myeloid leukemia patients post allogeneic hematopoietic stem cell transplantation: A first-in-human phase I study.
1/2022	Treating Relapsed/Refractory Acute Myeloid Leukemia with Chidamide, Fludarabine, Cytarabine and Granulocyte-Colony Stimulating Factor with Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation.
1/2022	Cytomegalovirus-Specific T Cells from Third-Party Donors Successfully Treated Refractory Cytomegalovirus Retinitis after Unrelated Umbilical Cord Blood Transplantation.
5/2021	Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival.
8/2015	[Efficacy analysis of unrelated cord blood transplantation for 58 acute myelogenous leukemia patients].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guangyu Sun Research Topics

Disease

14	Neoplasms (Cancer) 01/2024 - 12/2015
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 08/2015
5	Infections 10/2023 - 07/2018
4	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2023 - 08/2014
4	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2018
3	Hematologic Diseases (Blood Diseases) 10/2023 - 12/2018
2	Neoplasm Metastasis (Metastasis) 01/2024 - 07/2023
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 11/2023
2	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2015
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2024 - 01/2023
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 01/2022
2	Hematologic Neoplasms (Hematological Malignancy) 08/2023 - 09/2021
2	Leukemia 05/2023 - 01/2022
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 01/2022
2	Breast Neoplasms (Breast Cancer) 01/2019 - 12/2015
1	Non-Muscle Invasive Bladder Neoplasms 01/2024
1	Mycoses (Diseases, Fungus) 08/2023
1	Carcinoma (Carcinomatosis) 07/2023
1	Iron Overload 01/2023
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023
1	Margins of Excision 11/2022
1	Pathologic Complete Response 10/2022
1	Thrombocytopenia (Thrombopenia) 02/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	COVID-19 01/2022
1	Cytomegalovirus Retinitis 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Hemorrhagic Cystitis 09/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2020
1	Thrombotic Thrombocytopenic Purpura 04/2020
1	Stomach Neoplasms (Stomach Cancer) 03/2020
1	Lymphatic Metastasis 01/2019
1	Sepsis (Septicemia) 12/2018
1	Starvation 07/2018

Drug/Important Bio-Agent (IBA)

4	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2021
2	Circular RNAIBA 07/2023 - 01/2023
2	Hormones (Hormone)IBA 11/2022 - 01/2018
1	Epirubicin (Ellence)FDA LinkGeneric 01/2024
1	Fluo 4IBA 01/2024
1	VimentinIBA 01/2024
1	Gemcitabine FDA Link 01/2024
1	Cadherins (E-Cadherin)IBA 01/2024
1	CateninsIBA 01/2024
1	CalciumIBA 01/2024
1	hydroxycamptothecinumIBA 01/2024
1	homocamptothecinIBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Sincalide FDA Link 11/2023
1	AgarIBA 10/2023
1	Glucose (Dextrose)FDA LinkGeneric 10/2023
1	2,6-dinitrotoluene (DNT)IBA 08/2023
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 08/2023
1	Small Interfering RNA (siRNA)IBA 07/2023
1	LuciferasesIBA 07/2023
1	Capsules (Microcapsules)IBA 01/2023
1	IronIBA 01/2023
1	Deferasirox FDA Link 01/2023
1	Transcription Factors (Transcription Factor)IBA 10/2022
1	5-Methylcytosine (5 Methylcytosine)IBA 01/2022
1	MethyltransferasesIBA 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	AntibodiesIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	fludarabineIBA 01/2022
1	Coronavirus ReceptorsIBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	UbiquitinIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 09/2021
1	ChlorophyllIBA 09/2021
1	Photosystem II Protein Complex (Photosystem II)IBA 09/2021
1	Chlorophyll AIBA 09/2021
1	EnzymesIBA 09/2021
1	Carrier Proteins (Binding Protein)IBA 09/2021
1	Decitabine FDA Link 12/2020
1	thiamine triphosphorate (TTP)IBA 04/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2020
1	Capecitabine (Xeloda)FDA Link 03/2020
1	XELOXIBA 03/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2020
1	trioctyl phosphine oxide (TOPO)IBA 01/2019
1	CellophaneIBA 07/2018
1	Phosphates (Orthophosphate)IBA 07/2018

Therapy/Procedure

15	Transplantation 01/2024 - 08/2015
10	Therapeutics 01/2024 - 01/2017
7	Hematopoietic Stem Cell Transplantation 01/2023 - 12/2018
5	Drug Therapy (Chemotherapy) 01/2024 - 01/2019
2	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 11/2022
2	Immunotherapy 01/2022 - 01/2022
1	Induction Chemotherapy 01/2023
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2023
1	Blood Transfusion (Blood Transfusions) 01/2023
1	Operative Time 11/2022
1	Robotic Surgical Procedures 11/2022
1	Stem Cell Transplantation 12/2020
1	Neoadjuvant Therapy 03/2020